Tue
30
Sep
7:30 am

Definition

Positive symptoms are thoughts, behaviors, or sensory perceptions present in a person with a mental disorder, but not present in people in the normal population.

Description

Examples of positive symptoms are hallucinations (seeing, hearing, or smelling things not really there), delusions (belief in ideas not based on reality), disorganized speech (loose association between ideas, derailment of sentences, incoherence, illogical statements, excessive detail, and rhyming of words), or bizarre behavior. In other disorders, positive symptoms are primarily associated with schizophrenia or psychosis.

Mon
29
Sep
7:29 am

[#2: Edit Options>MightyAdsense>Adsense Code]

Definition

Polysubstance dependence refers to a type of substance dependence disorder in which an individual uses at least three different classes of substances indiscriminately and does not have a favorite drug that qualifies for dependence on its own.

Description

Polysubstance dependence is listed as a substance disorder in the Diagnostic and Statistical Manual of Mental Disorderspublished in 2000 (also known as the DSM-IV-TR). The DSM-IV-TRis the latest revision of the manual that it is used by mental health professionals to diagnose mental disorders. When an individual meets criteria for dependence on a group of substances (at least three different types used in the same 12-month period) he or she is given the diagnosis of polysubstance dependence. For example, an individual may use cocaine, sedatives, and hallucinogens indiscriminately (i.e., no single drug predominated; there was no “drug of choice”) for a year or more. The individual may not meet criteria for cocaine dependence, sedative dependence, or hallucinogen dependence, but may meet criteria for substance dependence when all three drugs are considered as a group.

Causes and symptoms

Causes

There is very little documented regarding the causes of polysubstance dependence.

Symptoms

The DSM-IV-TRspecifies that three or more of the following symptoms must occur at any time during a 12-month period (and cause significant impairment or distress) in order to meet diagnostic criteria for substance dependence:

  • Tolerance: The individual either has to use increasingly higher amounts of the drugs over time in order to achieve the same drug effect or finds that the same amount of the drug has much less of an effect over time than before. After using several different drugs regularly for a while, an individual may find that he or she needs to use at least 50% more of the amount they began using in order to get the same effect.
  • Withdrawal: The individual either experiences the withdrawal symptoms when he or she stops using the drugs or the individual uses drugs in order to avoid or relieve withdrawal symptoms.
  • Loss of control: The individual either repeatedly uses more drugs than planned or uses the drugs over longer periods of time than planned. For instance, an individual may begin using drugs (any combination of three or more types of drugs) on weekdays in addition to weekends.
  • Inability to stop using: The individual has either unsuccessfully attempted to cut down or stop using the drugs or has a persistent desire to stop using. An individual may find that, despite efforts to stop using drugs on weekdays, he or she is unable to do so.
  • Time: The individual spends a lot of time obtaining drugs, using drugs, being under the influence of drugs, and recovering from the effects of drugs.
  • Interference with activities: The individual either gives up or reduces the amount of time involved in recreational activities, social activities, and/or occupational activities because of the use of drugs. An individual may use drugs instead of engaging in hobbies, spending time with friends, or going to work.
  • Harm to self: The individual continues to use drugs despite having either a physical or psychological problem that is caused by or made worse by the use of drugs.

Demographics

Young adults (i.e., between the ages of 18 and 24) have the highest rates of use for all substances. Generally, males tend to be diagnosed with more substance use disorders.

Diagnosis

Individuals who abuse alcohol and other drugs usually meet criteria for substance abuse and/or dependence for each individual substance used. Multiple diagnoses are given in this situation (cocaine dependence, hallucinogen dependence, and sedative dependence, for example). Polysubstance dependence is reserved only for those situations when an individual uses multiple substances indiscriminately and meets criteria for dependence on these substances, taken as a whole.

Treatments

There is very little documented regarding the treatment of polysubstance dependence. However, several treatments have been tried. Psychological evaluation and tests may be used to assess the affected individual. The person may be admitted into a hospital or treatment center as an inpatient, and/or he or she may receive cognitive-behavioral therapy.

Prognosis

The course of substance dependence varies from short-lived episodes to chronic episodes lasting years. The individual with substance dependence may alternate between periods of heavy use with severe problems, periods of no use at all, and periods of use with few problems.

Prevention

The best single thing an individual can do to prevent polysubstance dependence is to avoid using drugs including alcohol altogether. On a larger scale, comprehensive prevention programs that utilize family, schools, communities, and the media (such as television) can be effective in reducing substance abuse.

Sat
27
Sep
7:27 am

[#3: Edit Options>MightyAdsense>Adsense Code]

Definition

Polysomnography is a series of tests performed on patients while they sleep. Polysomnography is a comprehensive overnight procedure that evaluates sleep disorders. It generally includes monitoring of the patient’s airflow through the nose and mouth, blood pressure, heartbeat as measured by an electrocardiograph, blood oxygen level, brain wave patterns, eye movements, and the movements of respiratory muscles and limbs. The word polysomnography is derived from the Greek root poly meaning “many,” the Latin noun somnus meaning “sleep,” and the Greek verb graphein meaning “to write.”

Purpose

Polysomnography is used to help diagnose and evaluate a number of sleep disorders. For instance, it can help diagnose sleep apnea, a common disorder in middle-aged and elderly obese men, in which the muscles of the soft palate in the back of the throat relax and close off the airway during sleep. Sleep apnea may cause the person to snore loudly and gasp for air at night. It may also cause the person to be excessively drowsy and likely to fall asleep during the day. Another syndrome often uncovered by polysomnography is narcolepsy. Persons with narcolepsy have sudden attacks of sleep and/or cataplexy (temporary loss of muscle tone caused by moments of emotion, such as fear, anger, or surprise, which causes people to slump or fall over), sleep paralysis or hallucinations while they are falling asleep.

Polysomnography is often used to evaluate such parasomnias (abnormal behaviors or movements during sleep) as sleepwalking; talking in one’s sleep; night-mares; and bed-wetting (enuresis). It can also be used to detect or evaluate seizures that occur in the middle of the night, when the patient and his or her family are unlikely to be aware of them.

Other problems uncovered by polysomnography include sleep-related psychiatric depression, asthma, and panic disorder. Polysomnography is generally not used if the sleep disorder has been clearly identified by the treating physician. It is also not used in cases of insomnia that have simple and obvious causes.

Precautions

Polysomnography is extremely safe, and no special precautions need to be taken.

Description

Polysomnography requires an overnight stay in a sleep laboratory. While the patient sleeps, he or she is monitored in a number of ways that can provide useful information.

One form of monitoring is electroencephalography (EEG), which involves the attachment of electrodes to the patient’s scalp to record his or her brain wave activity. The electroencephalograph records brain wave activity from different parts of the brain and charts them on a graph. The EEG not only helps doctors establish what stage of sleep the patient is in, but may also detect seizures.

Another form of monitoring is continuous electrooculography (EOG), which records eye movements. EOG is used to determine the time periods during which the patient is going through a stage of sleep called rapid-eye-movement (REM) sleep. Both EEG and EOG can be helpful in determining sleep latency (the time period between getting into bed and the onset of sleep); total sleep time; the time spent in each sleep stage; and the number of arousals from sleep.

The airflow through the patient’s nose and mouth are measured by heat-sensitive devices called thermistors. The thermistors can help detect episodes of apnea (stopped breathing), or hypopnea (inadequate or too-shallow breathing). Another test called pulse oximetry measures the amount of oxygen in the patient’s blood. Pulse oximetry can be used to assess the degree of oxygen starvation during episodes of hypopnea or apnea.

The electrical activity of the patient’s heart is also measured on an electrocardiogram, or EKG. Electrodes are attached to the patient’s chest. The electrodes pick up electrical activity from various areas of the heart. They help to detect cardiac arrythmias (abnormal heart rhythms), which may occur during periods of sleep apnea. The patient’s blood pressure is also measured, because some episodes of sleep apnea can raise blood pressure to dangerously high levels.

In some cases, sleep laboratories monitor the movement of the patient’s arms and legs during sleep. This measurement can be helpful in detecting such sleep disorders as periodic limb movements. Some sleep laboratories perform an additional test called multiple sleep latency testing (MSLT), which records several naps throughout the day. In addition, many sleep researchers prefer to evaluate the patient over a period of a few days rather than just one night. This approach is based on the recognition that the patient may need more than one night to adjust to the unfamiliar surroundings of the sleep laboratory.

Preparation

The patient may be asked to discontinue taking any medications, and avoid alcohol and strenuous exercise the day before the sleep analysis is performed. Before the patient goes to sleep, the technician hooks him or her up to all of the monitors being used.

Aftercare

After the test is completed, the monitors are detached from the patient. No special measures need to be taken after polysomnography. On occasion, skin irritation from the adhesive can develop in the areas where the electrodes have been attached to the patient.

Normal results

A normal result in polysomnography shows normal results for all parameters (EEG, EKG, blood pressure, eye movement, air flow, pulse oximetry, etc.) that were monitored throughout all stages of sleep.

Abnormal results

Polysomnography may yield a number of abnormal results, indicating one or more potential sleep disorders. For instance, abnormal transitions into and out of various stages of sleep, as documented by the EEG and the EOG, may be signs of narcolepsy. Reduced air flow through the nose and mouth, along with a fall in blood oxygen levels, may indicate apnea or hypopnea. If apnea is accompanied by abnormal patterns on the EKG or elevations in blood pressure, then the sleep apnea may be producing harmful effects. Frequent movements of the patient’s arms and legs may suggest a sleep disorder called periodic limb movement. A related condition that affects sleep as well as daytime movement is called restless legs syndrome. Polysomnography can also be used to diagnose bruxism, which is the chronic grinding of the teeth during sleep.

Thu
25
Sep
7:25 am

Definition

Play therapy refers to a method of psychotherapy with children in which a therapist uses a child’s fantasies and the symbolic meanings of his or her play as a medium for understanding and communication with the child.

Purpose

The aim of play therapy is to decrease those behavioral and emotional difficulties that interfere significantly with a child’s normal functioning. Inherent in this aim is improved communication and understanding between the child and his parents. Less obvious goals include improved verbal expression, ability for self-observation, improved impulse control, more adaptive ways of coping with anxiety and frustration, and improved capacity to trust and to relate to others. In this type of treatment, the therapist uses an understanding of cognitive development and of the different stages of emotional development as well as the conflicts common to these stages when treating the child.

Play therapy is used to treat problems that are interfering with the child’s normal development. Such difficulties would be extreme in degree and have been occurring for many months without resolution. Reasons for treatment include, but are not limited to, temper tantrums, aggressive behavior, non-medical problems with bowel or bladder control, difficulties with sleeping or having nightmares, and experiencing worries or fears. This type of treatment is also used with children who have experienced sexual or physical abuse, neglect, the loss of a family member, medical illness, physical injury, or any experience that is traumatic.

 

At times, children in play therapy will also receive other types of treatment. For instance, youngsters who are unable to control their attention, impulses, tendency to react with violence, or who experience severe anxiety may take medication for these symptoms while participating in play therapy. The play therapy would address the child’s psychological symptoms. Other situations of dual treatment include children with learning disorders. These youngsters may receive play therapy to alleviate feelings of low self-esteem, excessive worry, helplessness, and incompetency that are related to their learning problems and academic struggles. In addition, they should receive a special type of tutoring called cognitive remediation, which addresses the specific learning issues.

Precautions

Play therapy addresses psychological issues and would not be used to alleviate medical or biological problems. Children who are experiencing physical problems should see a physician for a medical evaluation to clarify the nature of the problem and, if necessary, receive the appropriate medical treatment. Likewise, children who experience academic difficulties need to receive a neuropsychological or in-depth psychological evaluation in order to clarify the presence of a biologically based learning disability. In both of these cases, psychological problems may be present in addition to medical ailments and learning disabilities, but they may not be the primary problem and it would not be sufficient to treat only the psychological issues. Alternatively, evaluations may show that medical or biological causes are not evident, and this would be important information for the parents and therapist to know.

Description

In play therapy, the clinician meets with the child alone for the majority of the sessions and arranges times to meet with parents separately or with the child, depending on the situation. The structure of the sessions is maintained in a consistent manner in order to provide a feeling of safety and stability for the child and parents. Sessions are scheduled for the same day and time each week and occur for the same duration. The frequency of sessions is typically one or two times per week, and meetings with parents occur about two times per month, with some variation. The session length will vary depending on the environment. For example, in private settings, sessions usually last 45 to 50 minutes while in hospitals and mental health clinics the duration is typically 30 minutes. The number of sessions and duration of treatment varies according to treatment objectives of the child.

During the initial meeting with parents, the therapist will want to learn as much as possible about the nature of the child’s problems. Parents will be asked for information about the child’s developmental, medical, social and school history, whether or not previous evaluations and interventions were attempted and the nature of the results. Background information about parents is also important since it provides the therapist with a larger context from which to understand the child. This process of gathering information may take one to three sessions, depending on the style of the therapist. Some clinicians gather the important aspects of the child’s history during the first meeting with parents and will continue to ask relevant questions during subsequent meetings. The clinician also learns important information during the initial sessions with the child.

Sessions with parents are important opportunities to keep the therapist informed about the child’s current functioning at home and at school and for the therapist to offer some insight and guidance to parents. At times, the clinician will provide suggestions about parenting techniques, about alternative ways to communicate with their child, and will also serve as a resource for information about child development. Details of child sessions are not routinely discussed with parents. If the child’s privacy is maintained, it promotes free expression in the therapist’s office and engenders a sense of trust in the therapist. Therapists will, instead, communicate to the parents their understanding of the child’s psychological needs or conflicts.

For the purposes of explanation, treatment can be described as occurring in a series of initial, middle and final stages. The initial phase includes evaluation of the problem and teaching both child and parents about the process of therapy. The middle phase is the period in which the child has become familiar with the treatment process and comfortable with the therapist. The therapist is continuing to evaluate and learn about the child, but has a clearer sense of the youngster’s issues and has developed, with the child, a means for the two to communicate. The final phase includes the process of ending treatment and saying goodbye to the therapist.

During the early sessions, the therapist talks with the child about the reason the youngster was brought in for treatment and explains that the therapist helps make children’s problems go away. Youngsters often deny experiencing any problems. It is not necessary for them to acknowledge having any since they may be unable to do so due to normal cognitive and emotional factors or because they are simply not experiencing any problems. The child is informed about the nature of the sessions. Specifically, the child is informed that he or she can say or play or do anything desired while in the office as long as no one gets hurt, and that what is said and done in the office will be kept private unless the child is in danger of harming himself.

Children communicate their thoughts and feelings through play more naturally than they do through verbal communication. As the child plays, the therapist begins to recognize themes and patterns or ways of using the materials that are important to the child. Over time, the clinician helps the child begin to make meaning out of the play. This is important because the play reflects issues which are important to the child and typically relevant to their difficulties.

When the child’s symptoms have subsided for a stable period of time and when functioning is adequate with peers and adults at home, in school, and in extracurricular activities, the focus of treatment will shift away from problems and onto the process of saying goodbye. This last stage is known as the termination phase of treatment and it is reflective of the ongoing change and loss that human beings experience throughout their lives. Since this type of therapy relies heavily on the therapist’s relationship with the child and also with parents, ending therapy will signify a change and a loss for all involved, but for the child in particular. In keeping with the therapeutic process of communicating thoughts and feelings, this stage is an opportunity for the child to work through how they feel about ending therapy and about leaving the therapist. In addition to allowing for a sense of closure, it also makes it less likely that the youngster will misconstrue the ending of treatment as a rejection by the therapist, which would taint the larger experience of therapy for the child. Parents also need a sense of closure and are usually encouraged to process the treatment experience with the therapist. The therapist also appreciates the opportunity to say goodbye to the parents and child after having become involved in their lives in this important way, and it is often beneficial for parents and children to hear the clinician’s thoughts and feelings with regards to ending treatment.

Preparation

It is recommended that parents explain to the child that they will be going to see a therapist, that they discuss, if possible, the particular problem that is interfering with the child’s growth and that a therapist is going to teach both parents and child how to make things better. As described earlier, the child may deny even obvious problems, but mainly just needs to agree to meet the therapist and to see what therapy is like.

Aftercare

Children sometimes return to therapy for additional sessions when they experience a setback that cannot be easily resolved.

Normal results

Normal results include the significant reduction or disappearance of the main problems for which the child was initially seen. The child should also be functioning adequately at home, in school, with peers and should be able to participate in and enjoy extracurricular activities.

Abnormal results

Sometimes play therapy does not alleviate the child’s symptoms. This situation can occur if the child is extremely resistant and refuses to participate in treatment or if the child’s ways of coping are so rigidly held that it is not possible for them to learn more adaptive ones.

Tue
23
Sep
7:24 am

Definition

Pimozide is an atypical antipsychotic drug used to treat serious motor and verbal tics associated with Tourette’s syndrome. It is sold under the brand name Orap.

Purpose

Pimozide is classified as an atypical antipsychotic drug. It is structurally similar to another drug, haloperidol, which was the first drug to be used in Tourette’s syndrome. Pimozide is most often used to treat symptoms of Tourette’s syndrome, although it has also been used for treating schizophrenia mania, and other behavioral disorders.

Description

Excess dopamine activity in the brain is associated with the verbal and physical tics observed in Tourette’s syndrome. Like haloperidol, pimozide is believed to inhibit the actions of the brain chemical, dopamine.

Pimozide is broken down by the liver and eliminated from the body by the kidneys. Because pimozide is associated with health risks, it should not be used for tics that are simply annoying or cosmetic. Pimozide should be used only in patients with severe symptoms after other drug therapy has been tried and failed.

Pimozide is available in 1-mg and 2-mg tablets.

Recommended dosage

The common starting dose of pimozide in adults is 1-2 mg per day. The dose may be increased every other day until 0.2 mg per kg (or 0.9 mg per pound) of body weight per day or 10 mg per day is reached, whichever is less. Doses that exceed 0.2 mg per kg per day or 10 mg daily are not recommended.

In children, the usual initial dose is 0.05 mg per kg daily, and increased every three days to a maximum dose of 0.2 mg per kg (or 10 mg) per day.

Periodically, the dosage of pimozide should be reduced to determine if tics are still present. Patients should be maintained on the lowest dose that is effective in treating their disorder.

Precautions

Pimozide may alter the rhythm of the heart. As a result, it should be used with caution in people with heart disease, and these patients should be observed carefully while receiving the drug.

Pimozide should not be taken with grapefruit juice.

Pimozide should be used with close physician supervision by people who have a history of seizure disorders, because it may increase the tendency to have seizures.

Pimozide may cause extreme drowsiness and should be used carefully by people who need to be mentally alert.

Patients should not take pimozide while pregnant or breast-feeding.

Pimozide should not be used by people with mild tics, by individuals taking stimulants such as methylphenidate (Ritalin), pemoline (Cylert), or dextroamphetamine (Dexedrine) since these drugs may cause tics.

Side effects

The most common side effects associated with pimozide are sleepiness, headache, stomach upset, muscle tightness, muscle weakness, difficulty moving, tremor, abnormal behavior, visual disturbances, and impotence.

Other side effects that might also occur with pimozide involve rapid heart rates or irregular heart rhythms, low blood pressure, constipation, dry mouth and eyes, rash, breast pain, breast milk production, loss of bladder control, or low blood cell counts.

Pimozide use may lead to the development of symptoms that resemble Parkinson’s disease. These symptoms may include a tight or mask-like expression on the face, drooling, tremors, pill-rolling motions in the hands, cog-wheel rigidity (abnormal rigidity in muscles characterized by jerky movements when the muscle is passively stretched), and a shuffling gait. Taking anti-Parkinson drugs benztropine mesylate or trihexyphenidyl hydrochloride along with the pimozide usually controls these symptoms.

Pimozide has the potential to produce a serious side effect called tardive dyskinesia. This syndrome consists of involuntary, uncoordinated movements that may appear late in therapy and not disappear even after the drug is stopped. Tardive dyskinesia involves involuntary movements of the tongue, jaw, mouth or face or other groups of skeletal muscles. The incidence of tardive dyskinesia increases with increasing age and with increasing dosage of pimozide. Women are at greater risk than men for developing tardive dyskinesia. There is no known effective treatment for tardive dyskinesia, although gradual (but rarely complete) improvement may occur over a long period.

An occasionally reported side effect of pimozide is neuroleptic malignant syndrome. This is a complicated and potentially fatal condition characterized by muscle rigidity, high fever, alterations in mental status, and cardiac symptoms such as irregular pulse or blood pressure, sweating, tachycardia (fast heartbeat), and arrhythmias (irregular heartbeat). People who think they may be experiencing any side effects from this or any other medication should talk to their physician promptly.

Interactions

If pimozide is used with bethanechol (Urecholine), clonidine (Catapres), fluoxetine (Prozac), indomethacin (Indocin), meperidine (Demerol), paroxetine (Paxil), quinidine, or trazodone (Desyrel), the side effects associated with pimozide may be increased.

There is an increased risk of irregular heart rhythms if pimozide is used with other antipsychotics, certain antidepressants, some heart drugs, and antibiotics like erythromycin.

The beneficial effects of pimozide may be reduced if used with bromocriptine (Parlodel), carbamazepine (Tegretol), levodopa (Larodopa, Sinemet), lithium, or phenobarbital.

Some antibiotics, antifungals, antidepressants, and drugs used for AIDS may prevent the breakdown of pimozide by the liver and thus, increase the amount of pimozide in the body. The combination of pimozide and the above classes of drugs should be used cautiously if at all.

Pimozide may interact with other central nervous system depressants such as alcohol, sleeping pills, antihistamines, and antidepressants.

Sun
21
Sep
7:22 am

Definition

Pica is a term that refers to cravings for substances that are not foods. Materials consumed by patients with pica include dirt, ice, clay, glue, sand, chalk, beeswax, chewing gum, laundry starch, and hair.

Description

Pica is the craving or ingestion of nonfood items. The cravings found in patients diagnosed with pica may be associated with a nutritional deficiency state, such as iron-deficiency anemia; with pregnancy; or with mental retardation or mental illness. The word picais derived from the Latin word for magpie, a species of bird that feeds on whatever it encounters.

The mental health professional’s handbook, the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (2000), which is abbreviated as DSM-IV-TR, classifies pica under the heading of “Feeding and Eating Disorders of Infancy or Early Childhood.” Adiagnosis of pica requires that the patient must persist in eating nonfood substances for at least one month. This behavior must be inappropriate for the child’s stage of development. Further, it must not be approved or encouraged by the child’s culture.

Causes and symptoms

Causes

The cause of pica is not known. Many hypotheses have been developed to explain the behavior. These have included a variety of such factors as cultural influences; low socioeconomic status; deficiency diseases; and psychological disorders.

Malnutrition is often diagnosed at the same time as pica. A causal link has not been established. Eating clay has been associated with iron deficiency; however, whether decreased iron absorption is caused by eating clay or whether iron deficiency prompts people to eat clay is not known. Some cultural groups are said to teach youngsters to eat clay. Persons with iron deficiency anemia have also been reported to chew on ice cubes. Again, the mechanism or causal link is not known.

Eating paint is most common among children from families of low socioeconomic status. It is often associated with lack of parental supervision. Hunger also may result in pica.

Among persons with mental retardation, pica has been explained as the result of an inability to tell the difference between food and nonfood items. This explanation, however, is not supported by examples of nonfood items that were deliberately selected and eaten by persons with limited mental faculties.

Pica, iron deficiency, and a number of other physiological disturbances in humans have been associated with decreased activity of the dopamine system in the brain. Dopamine is a neurotransmitter, or chemical that helps to relay the transmission of nerve impulses from one nerve cell to another. This association has led some researchers to think that there may be a connection between abnormally low levels of dopamine in the brain and the development of pica. No specific underlying biochemical disorders have been identified, however.

Risk factors for pica include the following:

  • parental/child psychopathology
  • family disorganization
  • environmental deprivation
  • pregnancy
  • epilepsy
  • brain damage
  • mental retardation
  • pervasive developmental disorders

Symptoms

Infants and children diagnosed with pica commonly eat paint, plaster, string, hair, and cloth. Older children may eat animal droppings, sand, insects, leaves, pebbles and cigarette butts. Adolescents and adults most often ingest clay or soil.

The symptoms of pica vary with the item ingested.

  • Sand or soil is associated with gastric pain and occasional bleeding.
  • Chewing ice may cause abnormal wear on teeth.
  • Eating clay may cause constipation.
  • Swallowing metal objects may lead to bowel perforation.
  • Eating fecal material often leads to such infectious diseases as toxocariasis, toxoplasmosis, and trichuriasis.
  • Consuming lead can lead to kidney damage and mental retardation.

Demographics

Pica tends to taper off as children grow older. The disorder occasionally continues into adolescence but is rarely observed in adults who are not disabled.

Pica is observed more commonly during the second and third years of life and is considered to be developmentally inappropriate in children older than 18–24 months. Research findings indicate that the disorder occurs in 25%–33% of young children and 20% of children in mental health clinics. Among individuals with mental retardation, pica occurs most often in those between the ages of 10–20 years. Among young pregnant women, the onset of pica is frequently associated with a first pregnancy in late adolescence or early adulthood. Although pica usually stops at the end of the pregnancy, it may continue intermittently for years.

Pica usually occurs with equal frequency among males and females. It is relatively uncommon, however, among adolescent and adult males of average intelligence who live in developed countries.

Diagnosis

Pica is often diagnosed in a hospital emergency room, when the child or adolescent develops symptoms of lead poisoning, bowel perforation, or other medical complications caused by the nonfood items that have been swallowed. Laboratory studies may be used to assess these complications. The choice of imaging or laboratory studies depends on the characteristics of the ingested materials and the resultant medical problems.

The examining doctor may order a variety of imaging studies in order to identify the ingested materials and treat the gastrointestinal complications of pica. These imaging studies may include the following:

  • abdominal x rays
  • barium examinations of the upper and lower gastrointestinal (GI) tracts
  • upper GI endoscopy to diagnose the formation of bezoars (solid masses formed in the stomach) or to identify associated injuries to the digestive tract

Films and studies may be repeated at regular intervals to track changes in the location of ingested materials.

Treatments

As of 2002, there is no standard treatment for pica. Currently, the most effective strategies are based on behavior modification, but even these treatments have achieved limited success. Pica associated with a nutritional deficiency often clears up when the missing nutrient is added to the patient’s diet.

Few studies have examined the efficacy of drug treatments for pica. Ongoing research, however, is exploring the relationship between pica and abnormally low levels of the neurotransmitter dopamine. This line of research may help to identify new medications for the treatment of pica. There is some evidence that medications used to manage severe behavioral problems in children may be useful in treating coexisting pica.

Lead poisoning resulting from pica may be treated by chelating medications, which are drugs that remove lead or other heavy metals from the bloodstream. The two medications most often given for lead poisoning are dimercaprol, which is also known as BAL or British Anti-Lewisite; and edetate calcium disodium (EDTA). A medical toxicologist (a doctor who specializes in treating poisoning cases) may be consulted regarding children’s dosages of these drugs.

In some cases, surgery may be required to remove metal objects from the patient’s digestive tract or to repair tissue injuries. It is particularly important to remove any objects made of lead (fishing weights, lead shot, pieces of printer’s type, etc.) as quickly as possible because of the danger of lead poisoning.

Prognosis

Pica frequently ends spontaneously in young children and pregnant women. Untreated pica, however, may persist for years, especially in persons with mental retardation and developmental disabilities.

Prevention

There is no known way to prevent pica at the present time. Educating people, particularly young couples with children, about healthy nutritional practices is the best preventive strategy.

Fri
19
Sep
7:21 am

Definition

Phonological disorder occurs when a child does not develop the ability to produce some or all sounds necessary for speech that are normally used at his or her age.

Description

Phonological disorder is sometimes referred to as articulation disorder, developmental articulation disorder, or speech sound production disorder. If there is no known cause, it is sometimes called “developmental phonological disorder.” If the cause is known to be of neurological origin, the names “dysarthria” or “dyspraxia” are often used. Phonological disorder is characterized by a child’s inability to create speech at a level expected of his or her age group because of an inability to form the necessary sounds.

There are many different levels of severity of phonological disorder. These range from speech that is completely incomprehensible, even to a child’s immediate family members, to speech that can be understood by everyone but in which some sounds are slightly mispronounced. Treatment for phonological disorder is important not only for the child’s development to be able to form speech sounds, but for other reasons, as well. Children who have problems creating speech sounds may have academic problems in subject areas such as spelling or reading. Also, children who sound different than their peers may find themselves frustrated and ridiculed, and may become less willing to participate in play or classroom activities.

Causes

Phonological disorder is often divided into three categories, based on the cause of the disorder. One cause is structural problems, or abnormalities in the areas necessary for speech sound production, such as the tongue or the roof of the mouth. These abnormalities make it difficult for children to produce certain sounds, and in some cases make it impossible for a child to produce the sounds at all. The structural problem causing the phonological disorder generally needs to be treated before the child goes into language therapy. This therapy is especially useful, because, in many of these cases, correction of the structural problem results in correction of the speech sound problem.

The second category of phonological disorder is problems caused by neurological problems or abnormalities. This category includes problems with the muscles of the mouth that do not allow the child sufficient fine motor control over the muscles to produce all speech sounds. The third category of phonological disorder is phonological disorder of an unknown cause. This is sometimes called “developmental phonological disorder.” Although the cause is not known, there is much speculation. Possible causes include slight brain abnormalities, causes rooted in the child’s environment, and immature development of the neurological system. As of 2002, there is research pointing to all of these factors, but no definitive cause has been found.

Symptoms

The symptoms of phonological disorder differ significantly depending on the age of the child. It is often difficult to detect this disorder, as the child with phonological disorder develops speech sounds more slowly than his or her peers; generally, however, he or she develops them in the same sequence. Therefore, speech that may be normal for a four-year-old child may be a sign of phonological disorder in a six-year-old.

Nearly all children develop speech sounds in the same sequence. The consonant sounds are grouped into three main groups of eight sounds each: the early eight, the middle eight, and the late eight. The early eight include consonant sounds such as “m,” “b,”, and “p.” The middle eight include sounds such as “t,” “g”, and “chi,” and the late eight include more complicated sounds such as “sh,” “th,” “z,” and “zh.” Many children do not normally finish mastering the late eight until they are seven or eight years old. As children normally develop speech sound skills, there are some very common mistakes that are made. These include the omission of sounds, (i.e., frequently at the end of words), the distortion of sounds, or the substitution of one sound for another. Often the substitution is of a sound that the child can more easily produce for one that he or she cannot.

Diagnosis

The diagnosis for phonologic disorder depends greatly on the age of the child in question. Children who are four years old may have speech production difficulties that show normal development for their age, while children who are eight years old and making the same mistakes may have phonological disorder. In children with phonological disorder, the pattern and order of speech sound acquisition is usually similar to that of normally developing children. However, the speech sound skills develop more slowly, so age is an important factor in determining a diagnosis of phonological disorder. Children with phonological disorder may make the same speech sound mistakes as younger, normally developing children. In some cases, however, children with phonological disorder have demonstrated more instances of omissions, substitutions, and distortions in their speech.

When exploring a diagnosis of phonological disorder, it is generally recommended that a physician check for other possible causes of the signs and symptoms. A child’s hearing should be checked, because speech sounds that are not heard well by a child cannot be imitated and learned well. In school-age children, reading comprehension should be checked to discover any other language disorders, which are sometimes present in addition to phonological disorder. Any general developmental delays should also be checked by the physician. It is important to remember that for some children whose native language is one other than English, the problems with speech sounds may result from poor crossover of sounds between the child’s languages. Therefore, when diagnosing a child with a different native language, it is recommended that tests involve the child’s first language, as well as English. Also, it must be remembered that in some parts of the country, normal pronunciation of some words is different from pronunciation in other parts of the country. Therefore a child’s background and history can be very important in making a diagnosis.

The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) states that for a diagnosis of phonological disorder to be made, three general criteria must be met. The first criterion is that the child is not developing speech sounds skills considered to be appropriate for his or her age group. Also, this lack of speech sound acquisition must be causing problems for the child at home, at school, or in other important aspects of the child’s life. If the child is mentally retarded, has problems with his or her speech muscles or hearing, or if there is environmental deprivation, a diagnosis of phonological disorder may still be appropriate. The diagnosis can only be made, however, if the lack of speech sounds skill is considered greater than the child’s other problems.

Demographics

Phonological disorder of unknown cause is considered significantly more common than phonological disorder that is caused by neurological or structural abnormalities. It has been estimated that 7–8% children who are five years old have phonological disorder with any cause (developmental phonological disorder). About 7.5% of children between the ages of three and eleven are thought to have development phonological disorder. Phonological disorder is more common in boys than it is in girls. Estimates suggest that two to four times as many boys as girls have the disorder. Children who have phonological disorder are more likely to have other language problems and disorders. Children with one or more family members who have this or similar language disorders are also considered to be more likely to have phonological disorders.

Treatment

Treatment by a speech-language pathologist is generally recommended for children with phonological disorders. The therapy will differ depending on an individual child’s needs, but generally takes the form of practicing sounds. Sometimes the child is shown the physical ways that the sound is made, such as where to place the tongue and how to form the lips. Repetition of the difficult sounds with the therapist is an integral part of treatment. There is debate, however, over the way that children with more severe forms of the disorder should be treated. Some therapists believe that the sounds that are learned later in development should be addressed first, even if the child has not developed the more simple sound skills. Other therapists believe that simple sounds should be treated first, as it is easier for children with phonological disorder to master them. One other school of thought is that when the child develops a sense of accomplishment when these sounds are mastered, and he or she will more willingly continue with treatment. There is ongoing research on this debate, and the results as of 2002 are still mixed.

Children who have phonological disorder because of neurological or structural problems that do not allow them to produce some sounds are often helped to find approximate alternatives for the sounds within the range of sounds that they are able to produce.

Prognosis

The prognosis for children with phonological disorder is generally good. For many children, the problem resolves spontaneously. It is reported that in 75% of children with mild-or-moderate forms of the disorder, and whose problems do not stem from a medical condition, the symptoms resolve before age six. In many other cases, children who receive treatment eventually develop normal or close to normal speech. In some cases, there may be mild effects that last until adulthood, but speech is completely understandable. For children with phonological disorder due to a neurological or structural cause, the outcome generally rests on how well the cause of the problem is treated.

Prevention

There is no known way to prevent phonological disorder. A healthy diet during pregnancy and regular prenatal care may help to prevent some of the neurological or structural problems that can result in the disorder.

Wed
17
Sep
7:19 am

Definition

Phenelzine is classified as a monoamine oxidase (MAO) inhibitor. In the United States, phenelzine is sold under the brand name Nardil.

Purpose

Phenelzine is used to treat certain types of serious depression and severe depression complicated by severe anxiety that do not respond to other antidepressant drugs.

Description

Phenelzine is a member of a class of drugs called monoamine oxidase inhibitors. Monoamine oxidase, or MAO, is an enzyme found throughout the body. In the brain, MAO breaks down norepinephrine and serotonin, two naturally occurring chemicals that are important in maintaining mental well-being and preventing depression. Monoamine oxidase inhibitors, such as phenelzine, reduce the activity of MAO. Less norepinephrine and serotonin are broken down, so their levels rise. This helps to lift depression.

Phenelzine is effective for treating depression, especially complicated types of depression that have not responded to more traditional antidepressants. However, phenelzine also affects the MAO enzyme in many other areas of the body. This accounts for the large number of serious side effects and drug interactions it causes.

Recommended dosage

Adults are usually started on 15 mg of phenelzine three times per day. This dosage can be increased to a maximum of 90 mg per day if lower doses are not effective, and the patient can tolerate the higher dose without excessive side effects. After the maximum benefits are achieved, the dosage is usually lowered over several weeks to the lowest level that is effective. This could be as little as 15 mg daily or every other day.

In general, phenelzine is not recommended for people over the age of 60. When it is used by the elderly, the starting dosage is usually 15 mg taken in the morning. This dose may be gradually increased over time to a maximum of 60 mg. Phenelzine is not frequently given to children under the age of 16, and recommended dosage in such cases has not been established.

Phenelzine can be taken with food or on an empty stomach. It should not be taken close to bedtime, because it can interfere with sleep. The benefits of this drug may not become apparent for as long as four to eight weeks. Patients should be aware of this and continue taking the drug as directed even if they do not see an immediate improvement.

Precautions

People with a history of congestive heart failure, high blood pressure, cardiovascular disease, headache, kidney disease, or liver disease should not take phenelzine or, if they do take it, they should be under careful medical supervision and monitoring. Children under the age of 16 and people with a history of low blood pressure, bipolar disorders, angina, hyperactivity, diabetes mellitus, seizures, suicidal thoughts, and overactive thyroid should discuss the risks and benefits of this drug with their physician, and a decision to treat should be made on an individual basis. If these patients receive phenelzine, it should be taken only under the careful supervision of a doctor. Evidence suggests that phenelzine should not be used during pregnancy or while nursing.

People taking phenelzine should get up slowly from a reclining position to prevent dizziness. Those who use phenelzine should use caution when operating heavy machinery or performing hazardous activities that require alertness.

It is very important for the doctor to determine the lowest dosage of phenelzine that produces benefits. When this dosage is exceeded, side effects and interactions increase substantially. Over-the-counter medications that contain decongestants or dextromethorphan (for example, some cough syrups and cold remedies) should not be taken while using phenelzine (see “Interactions,” below). In addition, foods and beverages that contain tyramine should not be eaten while using this medication. These foods include yeast or meat extracts, fermented sausage, overripe fruit, sauerkraut, cheese, and fava beans. Phenelzine should not be used within two weeks of undergoing surgery that requires anesthesia.

Side effects

The enzyme monoamine oxidase regulates functions throughout the body. Phenelzine decreases the activity of monoamine oxidase in all the areas of the body where it exists, not just in the brain. This is why phenelzine is capable of causing a wide variety of side effects in many different organ systems.

The most common and unavoidable side effects associated with phenelzine use are swelling of the feet and ankles, low blood pressure upon arising from a reclining position, and insomnia if taken near bedtime. Mild side effects and ones that are not frequent include skin rash, headache, dizziness, confusion, memory impairment, drowsiness, weakness, shakiness, muscle twitching, constipation, indigestion, appetite changes, and dry mouth. Although these side effects are considered mild, they should be reported to the treating doctor.

More serious side effects include hepatitis coupled with jaundice, high blood pressure crisis, excessive nervousness, and changes in heart rate. The high blood pressure crisis involves significantly increased blood pressure, severe headache, heart palpitations, nausea, vomiting, and sweating. These symptoms need immediate medical attention. Sexual function can be affected in both men and women.

Interactions

Phenelzine interacts with a long list of drugs. Some of these interactions can cause death. This section is not a complete list of interactions, but it includes the most serious ones. Patients must make sure that every health care professional who takes care of them (for example, doctors, dentists, podiatrists, optometrists, pharmacists, nurses) knows that they take phenelzine, as well as all of the other prescription, nonprescription, and herbal drugs they take.

All foods and beverages containing tyramine need to be avoided while taking this medication. Coffee, tea, and cola beverages should be restricted to one serving per day. Alcohol should not be used while taking phenelzine, because it can significantly increase blood pressure.

Any type of amphetamine and other stimulant should not be used, because this combination can increase blood pressure to dangerously high levels. Phenelzine should not be combined with other antidepressants, because of increased risk of dangerously high blood pressure and manic episodes. Patients taking phenelzine should stop the drug, then wait at least 14 days before starting any other antidepressant. The same holds true when discontinuing another antidepressant and starting phenelzine. Phenelzine combined with barbiturates can prolong the effects of barbiturates.

Phenelzine combined with clomipramine (Anafranil) can cause death. Diet drugs and decongestants containing compounds such as dextromethorphan should not be combined with phenelzine because of an increased risk of seizures and agitation. Phenelzine can decrease the effectiveness of high blood pressure drugs, such as guanadrel (Hylorel) and guanethidine (Ismelin). Phenelzine combined with the Parkinson disease drug levodopa (Dopar, Larodopa) can produce severely high blood pressure. Lithium should not be used with phenelzine because of the risk of developing extremely high fever. Phenelzine can prolong the effects of muscle relaxants when the two are combined.

Definition

Phencyclidine (PCP) is a street drug known as “angel dust” that causes physiological changes to the nervous and circulatory system, disturbances in thinking and behavior, and can cause hallucinations, psychotic disorder, mood disorder, and anxiety disorder.

Description

Phencyclidine (PCP) is the best known of several related drugs including ketamine, cyclohexamine, and dizocilpine. PCP was first synthesized by a pharmaceutical company in the 1950s and sold under the brand names Sernyl and Sernylan until 1967. It was hoped that PCP could be used as a dissociative anesthetic, because it produced a catatonic state in which patients were dissociated from their environment and from pain, but not unconscious. Problems with side effects as the drug wore off, including agitated behavior and hallucinations made PCP unsuitable for medical use. Ketamine (Ketlar, Ketaject) is less potent, has fewer side effects and is approved for use as a human anesthetic.

PCP became an illicit street drug in the mid-1960s. It was most commonly found in large cities such as New York and San Francisco, and even today, most users tend to live in urban areas. Into the 1970s, PCP appeared mainly as a contaminant of other illict drugs, especially marijuana and cocaine. This complicated diagnosis of PCP use, as many people did not know that they had ingested the drug.

PCP is easy to manufacture and is inexpensive. By the late 1970s, in some urban areas its use equaled that of crack cocaine. Use of PCP peaked between 1973 and 1979. Since 1980, PCP use has declined, although as with most illicit drugs, its popularity increases and decreases in cycles.

People who use PCP exhibit both behavioral and physiological signs. The effects of PCP are erratic, and serious complications can occur at relatively low doses. It is often difficult to distinguish PCP use from the use of other illicit drugs, and many people who use PCP also abuse other substances. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), which presents guidelines used by the American Psychiatric Association for diagnosis of mental disorders, phencyclidine can induce mood disorder, psychotic disorder, and anxiety disorder—but these classifications are somewhat controversial and not all are recognized by international psychiatric organizations. No human studies have been done on PCP tolerance and withdrawal. Animal studies suggest that both conditions occur, just as they do with many other abused drugs.

 

PCP is a Schedule II drug under the Controlled Substances Act. In its pure form, it is a white powder that dissolves easily in water. Once dissolved, the solution can be sprayed on tobacco or marijuana cigarettes. Less pure forms range from yellowish-tan to brown and can be a sticky mass. On the street PCP has many names including angel dust, devil dust, tranq, hog, crazy Eddie, rocket fuel, embalming fluid, wack, and ozone. Ketamine, which is legal and not regulated as a Schedule III controlled substance, also used illicitly, is known on the street as K, special K, and cat valium. Crack cocaine combined with PCP is sometimes called tragic magic. Marijuana laced with PCP is called love boat, killer weed, or crystal supergrass.

Causes and symptoms

Causes

PCP is easy to manufacture and is inexpensively available on the street in most cities, especially East Coast cities. It can be eaten, smoked, injected, snorted, and is readily soluble and will cross the skin barrier if liquid PCP is spilled on skin or clothing. The most common methods of ingestion are eating and smoking marijuana or tobacco on which liquid PCP has been sprayed. PCP is long acting. It accumulates in body fat, and flashbacks can occur as it is released from fat during exercise.

PCP binds to receptors in the brain and interferes with the chemical reactions that mediate the transmission of nerve impulses. It is deactivated slowly by the liver and excreted in urine. Although there are no controlled human studies on PCP intoxication, monkeys allowed free use of PCP will dose themselves repeatedly and maintain an almost continuous state of intoxication. They exhibit withdrawal symptoms if their supply of the drug is restricted. PCP is considered to be psychologically and possibly physically addictive in humans.

Symptoms

PCP produces both physiological and psychological symptoms. Effects of the drug are erratic and not always dose-dependent. Physical symptoms include:

  • involuntary rapid movements of the eyes vertically or horizontally
  • high blood pressure
  • racing heartbeat
  • dizziness and shakiness
  • drooling
  • increased body temperature
  • reduced response to pain
  • slurred speech
  • excessive sensitivity to sound
  • lack of muscle coordination
  • muscle rigidity or frozen posture
  • seizures
  • breakdown of muscle and excretion of muscle proteins in urine
  • coma
  • death

Psychiatric and social symptoms include:

  • disordered thinking and confusion
  • impaired judgment
  • belligerence
  • aggressiveness
  • agitation
  • impulsiveness and unpredictability
  • schizophrenic-like psychoses
  • hallucinations of sight, sound, or touch
  • memory impairment
  • difficulty in social-emotional relationships
  • chaotic lifestyle including difficulty functioning at work or school, legal and financial problems

PCP is known for its variability of symptoms, which change both from person to person and from exposure to exposure. In addition, symptoms come and go throughout a period of intoxication that can last from one to two hours for low dose exposure to one to four days for high dose exposure. Severity of symptoms is not always related to the size of the dose as measured by blood levels of the drug.

Three rough phases of intoxication have been established: behavioral toxicity, stuperous stage, and comatose stage. Many patients fluctuate between phases, and some present symptoms that do not fit neatly into any phase. In the behavioral toxicity stage, people tend to gaze blankly while their eyes dart horizontally or vertically. Muscle control is poor, and the person may make repetitive movements, grind the teeth, or grimace. Body temperature, heart rate, and respiration are mildly elevated. Vomiting and drooling may occur.

In the stuperous phase the eyes are wide open, and the person appears wide awake, but in a stupor. Seizures may occur if the person is stimulated. The eyes may dart in any direction while the gaze remains fixed. Body temperature is increased substantially. Heart and respiration rate are increased by about 25%. Muscles are rigid with twitching.

In the comatose stage, which may last from one to four days, the person is in a deep coma. The pupils are dilated and the eyes drift. Body temperature is elevated to the point of being life-threatening. The heart rate is dangerously high, increasing to about twice the normal level and blood pressure is dangerously low. Breathing may stop for brief periods (apnea). There is no response to pain, and the person sweats heavily. Death is possible, although most deaths with PCP occur in earlier stages through accidents or suicide.

Demographics

In the 1970s, PCP was used mainly by adolescents. Today the largest regular users are between the ages of 26 and 35. Men outnumber women users two to one, and men account for about three-quarters of PCP-related emergency room visits. Most users live in cities. About 90% of people who use PCP use other drugs as well, usually marijuana and alcohol. About 3% of substance abuse deaths are caused by PCP. Studies by the National Institute of Drug Abuse show that PCP use by high school students has declined steadily from about 13% in 1979 to about 4% in 1997.

Diagnosis

Diagnosis of PCP abuse or dependence is often complicated by the fact that symptoms are variable. Most people who use PCP use other drugs; and PCP can be a contaminant in other street drugs or can itself be contaminated with other chemicals. PCP use is also found among people with psychiatric disorders. In many ways, PCP mimics the symptoms of schizophrenia.

The American Psychiatric Association recognizes two levels of PCP disorders: PCP dependence and PCP abuse. In addition, it recognizes seven other PCP-induced psychiatric disorders.

PCP dependence is characterized by a psychological dependence or craving for the drug, as well as withdrawal symptoms if it is discontinued. Although physical dependence has been shown in animal studies with suggestions that physical dependence is present in heavy human users, no human studies have confirmed this. Heavy users may take the drug several times a day. They continue to use it despite experiencing psychological or physical problems. People with psychiatric disorders are more likely to have bad side effects from PCP than those without psychiatric problems. Adverse effects of PCP dependence can continue for weeks after the drug is discontinued.

Individuals with PCP abuse use the drug less regularly than those with PCP dependence. They experience both physical and psychological symptoms of PCP intoxication and often are unable to meet the normal demands of society (work, school, family responsibilities). Because PCP use impairs judgment and increases aggressiveness, they often are involved in accidents while under the drug’s influence.

Phencyclidine-induced disorders include:

  • PCP intoxication with or without perceptual disturbances
  • PCP intoxication delirium
  • PCP-induced psychotic disorder
  • PCP-induced mood disorder
  • PCP-induced anxiety disorder
  • PCP-induced disorders not otherwise specified

PCP intoxication and delirium are diagnosed by a history of recent PCP use, behavioral changes and physical changes that are not accounted for by any other substance use, medical condition, or psychiatric condition. PCP is present in the blood and urine. With PCP intoxication, a patient may have hallucinations but be aware that these are caused by PCP use.

PCP delirium is diagnosed when a patient exhibits muddled thinking, hostility, bouts of hyperactivity and aggressiveness, and schizophrenic-like symptoms, as well as the more severe physical symptoms listed above. PCP delirium can last for hours or days.

It may be difficult initially to separate PCP intoxication or delirium from other mental disorders, as symptoms may mimic depression, schizophrenia, mood disorders, conduct disorder, and antisocial personality disorder. People with PCP intoxication also have physical and psychological symptoms similar to those that occur with the use of other illicit drugs, complicating diagnosis. A complete physical and psychological history helps rule out these other conditions.

Treatments

People experiencing PCP intoxication or delirium often hurt themselves or others. They are generally kept in an environment where there is as little stimulation as possible. They are restrained only as much as is necessary to keep them from hurting themselves or others until the level of PCP in their bodies can be reduced. Antipsychotic medications may be used to calm patients in cases of PCP delirium.

There are no quick ways to rid the body of PCP. If the PCP has been eaten, stomach pumping or feeding activated charcoal may help keep the drug from being absorbed into the bloodstream. Physical symptoms such as high body temperature are treated as needed.

Most people recover from PCP intoxication or delirium without major medical complications. Many are habitual users who return to use almost immediately. There are no specific behavioral therapies to treat PCP use. Antidepressants are sometimes prescribed. Long-term residential treatment or intensive outpatient treatment along with urine monitoring offers some chance of success. Narcotics Anonymous, a self-help group, may be helpful for some patients.

Prognosis

Relapse and return to PCP use is common, even among people who have experienced severe medical and psychiatric complications from the drug. Since many users also abuse other drugs, their success in renouncing PCP is tied to their successful treatment for other addictions. Successful treatment takes persistence, patience, and a functional support system, all of which many users lack.

Prevention

PCP intoxication and related disorders can be prevented by not using the drug.

Definition

Pervasive developmental disorders are a group of conditions originating in childhood that involve serious impairment in several areas, including physical, behavioral, cognitive, social, and language development.

Description

Pervasive developmental disorders (PDDs) are thought to be genetically based, with no evidence linking them to environmental factors; their incidence in the general population is estimated at 1%. The most serious PDD is autism, a condition characterized by severely impaired social interaction, communication, and abstract thought, and often manifested by stereotyped and repetitive behavior patterns. Many children who are diagnosed with PDDs today would have been labeled psychotic or schizophrenic in the past.

The handbook used by mental health professionals to diagnose mental disorders such as PDDs is the Diagnostic and Statistical Manual of Mental Disorders. The 2000 edition of this manual (fourth edition, text revised) is known as the DSM-IV-TR. Published by the American Psychiatric Association, the DSM contains diagnostic criteria, research findings, and treatment information for mental disorders. It is the primary reference for mental health professionals in the United States.

Besides autism, the DSM lists several other conditions as PDDs:

Rett’s disorder

Characterized by physical, mental, and social impairment, this syndrome appears between the ages of five months and four years in children whose development has been normal up to that point. Occurring only in girls, it involves impairment of coordination, repetitive movements, a slowing of head growth, and severe or profound mental retardation, as well as impaired social and communication skills.

Childhood disintegrative disorder

This disorder is marked by the deterioration of previously acquired physical, social, and communication skills after at least two years of normal development. More common in males than females, it first appears between the ages of two and 10 (usually at three or four years of age), and many of its symptoms resemble those of autism. Other names for this disorder are Heller’s syndrome, dementia infantilis, and disintegrative psychosis. It sometimes appears in conjunction with a medical condition such as Schilder’s disease, but usually no organic cause can be found.

Asperger’s disorder

Children with this disorder have many of the same social and behavioral impairments as autism, except for difficulties with language. They lack normal tools of social interaction, such as the ability to meet someone else’s gaze, use appropriate body language and gestures, or react to another person’s thoughts and feelings. Behavioral impairments include the repetitive, stereo-typed motions and rigid adherence to routines that are characteristic of autism. Like childhood disintegrative disorder, Asperger’s disorder is more common in males than females.

Prognosis

In general, the prognosis in each of these conditions is tied to the severity of the illness.

The prognosis for Asperger’s syndrome is more hopeful than the others in this cluster. These children are likely to become functional, independent adults, but will always have problems with social relationships. They are also at greater risk for developing serious mental illness than the general population.

The prognosis for autistic disorder is not as good, although great strides have been made in recent years in its treatment. The higher the patient’s intelligence quotient (IQ) and ability to communicate, the better the prognosis. However, many patients will always need some level of custodial care. In the past, most of these individuals were confined to institutions, but many are now able to live in group homes or supervised apartments. The prognosis for childhood disintegrative disorder is the least favorable. These children will require intensive and long-term care.